Natural hormone shows “promise” in IVF, say scientistsBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4732 (Published 21 July 2014) Cite this as: BMJ 2014;349:g4732
- Matthew Limb
Research into a new method to stimulate ovulation in women who are undergoing in vitro fertilisation (IVF) treatment has produced “promising” results, say scientists. Twelve healthy babies were born to 10 women after 53 women were given a single injection of the natural hormone kisspeptin to mature their eggs.
Researchers described the pregnancy rate of 23% (12 of 53) as a “good outcome” when compared with standard conventional IVF therapy.
The trial was carried out by Imperial College London and Imperial College Healthcare NHS Trust and funded by the Medical Research Council, the National Institute for Health Research, and the Wellcome Trust. The findings were published on 18 July in the Journal of Clinical Investigation.1 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial